Variant · Snv
TAP1 NM_000593.6(TAP1):c.598+17G>T
CI-VAR-00196148Explore in graph →NM_000593.6:c.598+17G>TClinVar 1165698 rs55967815
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1165698 | Benign | criteria provided, multiple submitters, no conflicts | 2 | MHC class I deficiency; Uterine corpus endometrial carcinoma; Sarcoma; Hepatocellular carcinoma; Cervical cancer; Uveal melanoma; Acute myeloid leukemia; Malignant tumor of esophagus; Gastric cancer; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Thymoma; Cholangiocarcinoma | germline | 3 | Feb 02, 2026 | clinvar |